AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinker, K.
Right arrow Articles by Trattnig, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinker, K.
Right arrow Articles by Trattnig, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.3930
AJR 2008; 191:1391-1396
© American Roentgen Ray Society


Original Research

Longitudinal Evaluation of Cartilage Composition of Matrix-Associated Autologous Chondrocyte Transplants with 3-T Delayed Gadolinium-Enhanced MRI of Cartilage

Katja Pinker1, Pavol Szomolanyi2, Goetz C. Welsch1, Tallal C. Mamisch3, Stefan Marlovits4, Andreas Stadlbauer5 and Siegfried Trattnig1

1 Department of Radiology, MR Centre of Excellence, Medical University Vienna, Lazarettg. 14, 1090. Vienna, Austria.
2 Department of Imaging Methods, Institute of Measurement Science, Slovak Academy of Sciences, Bratislava, Slovak Republic.
3 Orthopedic Surgery Department, Inselspital, Bern, Switzerland.
4 Department of Traumatology, Centre for Joints and Cartilage, Medical University Vienna, Vienna, Austria.
5 Department of Radiology, Landesklinikum St. Poelten, St. Poelten, Austria.

Received March 1, 2008; accepted after revision May 30, 2008.

 
Funding provided by the Austrian Science Fund (FWF) P-18110-B15.

Address correspondence to S. Trattnig (siegfried.trattnig{at}meduniwien.ac.at).


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The purposes of this study were to use delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) to evaluate the zonal distribution of glycosaminoglycans (GAGs) in normal cartilage and repair tissue and to use 3-T MRI to monitor the GAG content in matrix-associated autologous chondrocyte transplants.

SUBJECTS AND METHODS. Fifteen patients who underwent matrix-associated autologous chondrocyte transplantation in the knee joint underwent MRI at baseline and 3-T follow-up MRI 1 year later. Total and zonal changes in longitudinal relaxivity ({delta}R1) and relative {delta}R1 were calculated for repair tissue and normal hyaline cartilage and compared by use of analysis of variance.

RESULTS. There was a significant difference between the mean {delta}R1 of repair tissue and that of reference cartilage at baseline and follow-up (p < 0.001). There was a significant increase in {delta}R1 value and a decrease in GAG content from the deep layer to the superficial layer in the reference cartilage and almost no variation and significantly higher values for the repair tissue at both examinations. At 1-year follow-up imaging, there was a 22.7% decrease in {delta}R1 value in the deep zone of the transplant.

CONCLUSION. T1 mapping with dGEMRIC at 3 T shows the zonal structure of normal hyaline cartilage, highly reduced zonal variations in repair tissue, and a tendency toward an increase in global and zonal GAG content 1 year after transplantation.

Keywords: 3 T • articular cartilage • autologous chondrocyte transplantation • dGEMRIC • high field strength • MRI


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
MRI of articular cartilage and of cartilage repair tissue in the knee joint has markedly improved owing to the development of clinical high-field-strength MRI systems operating at 3 T. The improved performance is achieved with use of higher static magnetic field strength, higher gradient strength, and dedicated coils such as phased-array coils [17]. The combination of these technologic improvements enables high-resolution im aging of cartilage within a reasonable time [810]. New surgical techniques of cartilage repair, such as autologous chondrocyte transplantation and matrix-associated autologous chondrocyte transplantation, have been developed and integrated into clinical routine [1116]. An advanced method of noninvasive quantitative assessment of the biochemical status of a graft is warranted to clarify development of the matrix-associated autologous chondrocyte graft over time and to validate the efficacy of the technique. As proven in several scientific and clinical studies, delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) is the method of choice for visualization and quantitative evaluation of relative glycos aminoglycan (GAG) con cen tration in articular cartilage, which reflects the biochemical status of both normal articular cartilage and cartilage repair tissue [8, 9, 1719].

GAGs are the main source of fixed-charge density in cartilage. Because GAGs are responsible for the biomechanical protection of cartilage and repair tissue, GAG concentration is an indicator of cartilage graft maturation. Gadolinium diethylene triamine pentaacetate anion (gadopentetate dimeglumine2–) equilibrates in inverse relation to fixed-charge density, which is directly related to GAG concentration. Therefore, T1, which is determined by gadopentetate dimeglumine2– concentration, becomes a specific measure of tissue GAG concentration and distribution [17, 20, 21]. GAG concentration in articular cartilage, however, is not uniform but has a zonal distribution that has been depicted in anatomic microscopic cross-sectional studies [5, 8, 9].

To our knowledge, no in vivo 3-T imaging study has been conducted to evaluate the zonal distribution of GAGs in both normal articular cartilage and cartilage repair tissue after matrix-associated autologous chondrocyte transplantation. Nor has such a study been conducted to track the development of GAGs within a graft over time. GAG development would reflect not only biochemical status but also maturation of a graft and thus might be used in a biomarker technique for assess ment of graft quality. The aims of our study were, first, to evaluate the zonal distribution of GAGs in normal hyaline cartilage and repair tissue in the knee joint by use of quantitative T1 mapping with the 3-T dGEMRIC technique and, second, to monitor, with normal hyaline cartilage as a reference, the development of relative GAG content of grafts 1 year after matrix-associated autologous chondrocyte transplantation.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Patient Population
Fifteen patients (two women, 13 men; mean age: 37.8 years; range, 21–54 years; mean postoperative interval, 21.1 ± 13.9 [SD] months) who underwent matrix-associated autologous chondrocyte transplantation surgery on the knee joint were included in this longitudinal quantitative T1 mapping study. All patients underwent quantitative T1 mapping with dGEMRIC twice: one baseline examination and a 1-year follow-up examination. The study was approved by the ethics commission at our institution. All patients gave written informed consent to participate in the study and were in good clinical condition with no known contraindications to MRI or to IV administration of standard MRI contrast agents. In 12 patients the matrix-associated autologous chondrocyte graft was located on the medial femoral condyle and in three patients on the lateral femoral condyle. In all patients, a hyaluronan-based scaffold (Hyalograft C, Fidia Advanced Biopolymers) was used as the biomaterial for the matrix-associated autologous chondrocyte transplantation procedure.

The mean defect size was assessed with arthroscopy and was approximately 5.8 cm2 (range, 2.6–12.4 cm2). The same trauma surgeon using the same surgical technique in all operations performed the surgical procedure on all patients. In 14 patients trauma was the cause of the chondral defect of the knee; the other patient had no known history of trauma.

Image Acquisition
All patients were examined on a 3-T MRI unit (Magnetom Trio, Siemens Medical Solutions) with an eight-channel phased-array knee coil. Quantitative T1 mapping was performed with a sagittal 3D gradient-recalled echo sequence with the dual flip-angle excitation pulses introduced by Trattnig et al. [22]. The following sequence parameters were used: TR/TE, 50/3.67; field of view, 183 x 200 mm; matrix size, 317 x 384; in-plane resolution, 0.6 x 0.5 mm; slice thickness, 1 mm; one slab of 36 slices covering the compart ment of interest; bandwidth, 130 Hz/pixel; imaging time, 6 minutes 53 seconds. The sequence was performed with two flip angles, first 35° and then 10°, before and after IV administration of anionic gadopentetate dimeglumine2– (Magnevist, Bayer Schering Pharma). For contrast-enhanced MRI, the protocol introduced by Burstein et al. [1] was used, that is, administration of a bolus of 0.2 mmol of contrast agent per kilogram of body weight. After injection, the patient moderately exercised the knee by walking up and down stairs for approximately 20 minutes [23]. Ninety minutes after contrast administration, the contrast-enhanced MR images were obtained. To allow the contrast agent to penetrate the articular cartilage and the cartilage transplant, the physical activity and delay of contrast-enhanced image acquisition are crucial. The same slab orientation was used for unenhanced and contrast-enhanced images. At the baseline and follow-up examinations, the orientation was achieved by identical positioning of the coil and the knee joint and use of an isotropic 3D sequence to define the identical sagittal planes before and after contrast administration.

MR images of the femorotibial compartment were acquired in the sagittal plane. A 3D doubleecho steady-state (DESS) sequence (15.1/5.11; field of view, 150 x 150 mm; matrix size, 250 x 250; in-plane resolution, 0.6 x 0.6 mm; slice thickness, 0.6 mm; flip angle, 25°; sensitivity-encoding factor, 2; imaging time, 5 minutes 39 seconds) was used for morphologic evaluation of the graft and the hyaline cartilage [2].

Data Analysis
All MR images, baseline and follow-up, were analyzed in consensus by a radiologist with 15 years of experience in musculoskeletal imaging and a resident with experience in MRI of the cartilage. Both observers were blinded to patient group. Morphologic MR images acquired with the DESS sequence were used for identification of the graft. If the graft was not easily identified, surgical reports and drawings were consulted. In all patients, three consecutive slices covering the cartilage repair tissue were selected and subjected to further analyses. For all patients, special care was taken that the same slices were selected for the baseline and follow-up examinations.

On the basis of results of a study by Trattnig et al. [22], the slab was positioned so that the graft was centered within the slab. Care was taken that the regions of interest (ROIs) for assessment of T1 values were completely within the region of the cartilage transplant. The graft was divided into two equally wide zones, specifically, a deep zone and a superficial zone. In each zone, ROIs with a mean pixel count of 100–150 were manually drawn. For standardization of the procedure, all ROIs were drawn by the musculoskeletal expert. A region of normal-appearing hyaline cartilage in the same knee joint was used as a reference, and an ROI with a mean pixel count of 100–150 was manually drawn. For verification of the normal appearance of the selected reference area, the isotropic DESS sequence was used. Again, these reference sites were divided into deep and superficial zones of equal width, and ROIs were manually drawn for assessment of T1 relaxation times. The mean global and zonal T1 relaxation times from all ROIs within the cartilage transplants were calculated. Values were compared with mean global and zonal values of T1 relaxation times of the ROIs of the reference.

For calculation of T1 maps, the DICOM images of the two measurements with different excitation pulse flip angles were exported with interactive data language software (IDL, version 6.0; ITT Corporation). The T1 time constant was calculated on a pixel-by-pixel basis (j, k) according to the following equation [11, 24]:

Formula
where T1cj,k is the T1 value, Qj,k is the quotient–pixel values, and TR is the repetition time. No filtering was applied to the images. Pseudocolor cartilage images were calculated with the built-in standard IDL color palette number 4, and the cartilage regions were segmented manually.

Quantitative measurements of R1 = 1/T1 in 1/s were made for the baseline and follow-up examinations. In agreement with previously published information [25, 26], measurements of longitudinal relaxivity before contrast administration (R1unenhanced), longitudinal relaxivity after contrast administration (R1contrast-enhanced), and the difference between R1unenhanced and R1contrast-enhanced ({delta}R1 = R1contrast-enhanced – R1unenhanced) were acquired for both the transplant and the reference cartilage in all patients in all locations described earlier. In addition, the relative ratio of {delta}R1 for repair tissue to {delta}R1 for normal cartilage was calculated for both transplant and reference cartilage in all patients in all locations.


Figure 1
View larger version (35K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A 24-year-old man 6 months after matrix-associated autologous chondrocyte transplantation. Color-coded contrast-enhanced T1 maps of cartilage at baseline (A) and follow-up (B) show significantly lower T1 values in transplant area than in normal hyaline cartilage. Arrows (B) indicate borders of transplant. Pink indicates zonal regions of interest in normal cartilage and transplant.

 


Figure 2
View larger version (51K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B 24-year-old man 6 months after matrix-associated autologous chondrocyte transplantation. Color-coded contrast-enhanced T1 maps of cartilage at baseline (A) and follow-up (B) show significantly lower T1 values in transplant area than in normal hyaline cartilage. Arrows (B) indicate borders of transplant. Pink indicates zonal regions of interest in normal cartilage and transplant.

 
Statistical Analysis
Three-way analysis of variance with a random factor was performed with SPSS for Windows (SPSS Institute). Differences between cartilage repair regions and normal weight-bearing cartilage sites were considered statistically significant at p < 0.05.


Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Global Values
In all measurements for all patients, the mean {delta}R1 (in 1/s) of the cartilage transplant was significantly higher than the mean {delta}R1 of normal hyaline cartilage (Fig. 1A, 1B). At the baseline examination, the mean global {delta}R1 for the cartilage repair transplant was 2.11 ± 0.79 versus 0.98 ± 0.37 at the reference site. At the 1-year follow-up examination, the mean global {delta}R1 for the cartilage transplant was 1.84 ± 0.61 versus 0.97 ± 0.4 at the reference site. At both baseline and follow-up examinations, the difference in global {delta}R1 values of the cartilage transplant and the control cartilage was statistically significant (p < 0.001). The mean relative {delta}R1 was 2.26 ± 0.67 for the baseline examination and 2.07 ± 0.69 for the follow-up examination. The difference in relative {delta}R1 at both time points was not statistically significant (p = 0.44). The relative {delta}R1 values of the cartilage transplant for all patients at the baseline and follow-up examinations are depicted in Figure 2.


Figure 3
View larger version (17K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 Graph shows relative change in longitudinal relaxivity ({delta}R1) values of matrix-associated autologous chondrocyte transplants at baseline (gray) and 1-year follow-up (white). Most patients had at least moderate to minor decrease in relative {delta}R1 over time, which corresponds to slight increase in glycosaminoglycan content in cartilage repair tissue.

 

Zonal Variation
The {delta}R1 values for the deep and superficial zones of the reference cartilage and cartilage transplant in all patients are shown in Table 1.


View this table:
[in this window]
[in a new window]

 
TABLE 1: Change in Longitudinal Relaxivity for Deep and Superficial Zones of Reference Cartilage and Cartilage Transplants

 

Reference Cartilage
At the baseline examination, the mean {delta}R1 values for the zonal variations of the reference cartilage were 0.85 ± 0.438 for the deep layer and 1.168 ± 0.435 for the superficial layer. The increase in {delta}R1 from the deep to the superficial zone of the reference cartilage was statistically significant (p = 0.021). At the 1-year follow-up examination, the mean {delta}R1 for the zonal variations of the reference cartilage was 0.846 ± 0.542 for the deep layer and 1.147 ± 0.349 for the superficial layer at the reference site. The increase in {delta}R1 values from the deep to the superficial zone of the reference cartilage again was statistically significant (p = 0.023).

Cartilage Transplant
At the baseline examination, the mean {delta}R1 for the zonal variations of the cartilage transplant was 2.369 ± 1.25 for the deep layer and 1.972 ± 0.648 for the superficial layer. At the 1-year follow-up examination, the mean {delta}R1 of the cartilage transplant was 1.833 ± 0.725 for the deep layer and 1.912 ± 0.625 for the superficial layer. At both time points the zonal variations of the cartilage transplant were not statistically significant. However, there was a 22.7% decrease in {delta}R1 for the deep zone of the cartilage transplant from 2.369 at baseline to 1.833 at follow-up. Although these findings were not statistically significant (p = 0.163), the changes in the deep zone were more pronounced than those in the superficial zone, where almost no change occurred (1.972 at baseline, 1.912 at follow-up (p = 0.687).


Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
In this longitudinal 1-year follow-up study, we used quantitative T1 mapping with dGEMRIC to evaluate the zonal distribution of GAGs in normal and transplant knee cartilage. The resolution used in this study allowed us to visualize and quantify the spatial distribution of relative GAG concentrations in cartilage transplants and healthy hyaline cartilage with 3-T imaging and to monitor the development of the relative GAG content of the graft after 1 year of follow-up of patients who had undergone matrix-associated autologous chondrocyte transplantation. Healthy hyaline cartilage was used as a reference. To our knowledge, our study was the first to evaluate the zonal distribution of GAGs in both normal hyaline cartilage and cartilage transplants after matrix-associated autologous chondrocyte transplantation and the development of GAGs within the graft over a 1-year follow-up period. Because results of previous studies have shown the necessity of measuring native T1 values for exact evaluation of relative GAG content at the repair site, we calculated {delta}R1 to monitor relative GAG content at the repair site at both baseline and follow-up examinations.

In an in vitro study, Wayne et al. [27] found that use of the ratio of T1 after gadolinium enhancement to T1 before contrast administration made it possible to differentiate collagenase- and chondroitase-treated cartilage. The T1 values after gadolinium enhancement alone were significantly different between treated and untreated cartilage. In a study with a small number of patients who had undergone autologous chondrocyte transplantation, Watanabe et al. [26] found a correlation only between absolute GAG content and relative change in relaxation rate.

The finding by Williams et al. [28] of a mean {delta}R1 of 0.61 ± 0.19 (range, 0.08–0.9) in healthy cartilage emphasizes the importance of calculation of individual ratios, such as relative {delta}R1, between repair tissue and normal hyaline cartilage. In agreement with the findings by Watanabe et al. [26], we found significantly higher {delta}R1 values for transplant than for reference site cartilage in all patients at both baseline and follow-up examinations. These findings and the findings in previous studies by Trattnig et al. [22], who investigated the {delta}R1 of cartilage transplants and normal hyaline cartilage at different postoperative intervals, suggest that, although there is maturation of the graft with a slight increase in relative GAG content over time, the {delta}R1 of a cartilage transplant is always significantly higher than the {delta}R1 of normal cartilage. This finding indicates that relative GAG content probably never reaches the level of healthy cartilage tissue.

GAG concentration in articular cartilage is not uniform. It has a zonal organization with a decrease in GAG content from the deep to the superficial layers of the cartilage, as depicted in anatomic, microscopic, cross-sectional studies [5, 8, 9]. In our study, this zonal GAG distribution was confirmed by a corresponding zonal distribution of {delta}R1 values in normal articular cartilage at both the baseline and follow-up examinations. However, in the cartilage transplant there was almost no zonal variation of GAGs with {delta}R1 values of 2.369 s–1 for the deep to 1.972 s–1 for the superficial zone at baseline and 1.833 s–1 for the deep to 1.912 s–1 for the superficial zone at follow-up. During graft maturation, there was a slight increase in GAG content with a 22.7% decrease in {delta}R1 value from 2.369 in the deep zone at baseline to 1.833 at the 1-year follow-up examination of the cartilage transplant, indicating a greater increase in GAG content in the deep zone. These findings, however, were not statistically significant. Moreover, at both time points cartilage transplant had statistically significantly higher global and zonal {delta}R1 values in both zones compared with normal hyaline cartilage. The global {delta}R1 was 2.11 for the cartilage transplant and 0.98 for the reference site at baseline and 1.84 for the cartilage transplant versus 0.97 for the reference site at follow-up. These findings support the results of studies by Tins et al. [29], Roberts et al. [30], and Moriya et al. [31], who investigated the histologic features of grafts 1 year after matrix-associated autologous chondrocyte transplantation for management of femoral condylar defects. Those authors found varied mixtures of hyaline and fibrocartilage, which seemed to indicate that the histologic composition of cartilage transplant is different from that of normal cartilage.

Because minor zonal variations and changes in zonal {delta}R1 values of the cartilage transplant, mainly in the deep zone, were detected, baseline evaluation and monitoring of the development of zonal {delta}R1 values may be a biomarker technique for assessing the initial quality of a cartilage transplant and development of the transplant over time. This technique may complement evaluation of zonal differentiation with T2 mapping and facilitate definition of the organization of cartilage transplants. These preliminary findings, however, need to be investigated further and validated in clinical studies with larger numbers of patients.

A limitation of this study was the relatively small number of patients included. Another was that histopathologic specimens were not available for direct comparison. Because, however, most of the patients had a good or excellent clinical outcome, there was no clinical indication for arthroscopic biopsy of the cartilage transplant, and the patients refused this procedure. To overcome this limitation, intraindividual comparison of {delta}R1 values with the values at a remote weight-bearing cartilage site in the same knee joint was performed. Because of the lack of arthroscopic correlation, the intactness of this reference site was determined with conventional cartilage MRI.

The dGEMRIC technique, based on 3D gradient-recalled echo sequences with two flip-angle excitation pulses can be used for zonal T1 mapping of normal hyaline cartilage and cartilage transplants. The dGEMRIC technique shows a zonal GAG content distribution in normal hyaline cartilage and a highly reduced zonal structure in cartilage transplant. Quantitative T1 mapping of cartilage shows a statistically insignificant tendency toward an increase in both global and zonal GAG content mainly in the deep zone over a follow-up period of 1 year in patients who have undergone matrix-associated autologous chondrocyte transplantation in the knee joint.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Burstein D, Velyvis J, Scott KT, et al. Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med 2001;45 : 36–41[CrossRef][Medline]
  2. Eckstein F, Hudelmaier M, Wirth W, et al. Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis2006; 65:433 –441[Abstract/Free Full Text]
  3. Chung CB, Frank LR, Resnick D. Cartilage imaging techniques: current clinical applications and state of the art imaging. Clin Orthop Relat Res 2001;391 [suppl]:S370 –S378[CrossRef][Medline]
  4. Craig JG, Go L, Blechinger J, et al. Three-tesla imaging of the knee: initial experience. Skeletal Radiol2005; 34:453 –461[CrossRef][Medline]
  5. Huber M, Trattnig S, Lintner F. Anatomy, biochemistry, and physiology of articular cartilage. Invest Radiol2000; 35:573 –580[CrossRef][Medline]
  6. Nehrer S, Minas T. Treatment of articular cartilage defects. Invest Radiol 2000;35 : 639–646[CrossRef][Medline]
  7. Trattnig S, Mlynarik V, Huber M, Ba-Ssalamah A, Puig S, Imhof H. Magnetic resonance imaging of articular cartilage and evaluation of cartilage disease. Invest Radiol 2000;35 : 595–601[CrossRef][Medline]
  8. Bashir A, Gray ML, Boutin RD, Burstein D. Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging. Radiology 1997;205 : 551–558[Abstract/Free Full Text]
  9. Bashir A, Gray ML, Hartke J, Burstein D. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med 1999; 41:857 –865[CrossRef][Medline]
  10. Weckbach S, Mendlik T, Horger W, Wagner S, Reiser MF, Glaser C. Quantitative assessment of patellar cartilage volume and thickness at 3.0 tesla comparing a 3D-fast low angle shot versus a 3D-true fast imaging with steady-state precession sequence for reproducibility. Invest Radiol 2006; 41:189 –197[CrossRef][Medline]
  11. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331 : 889–895[Abstract/Free Full Text]
  12. Marlovits S, Zeller P, Singer P, Resinger C, Vecsei V. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol 2006; 57:24 –31[CrossRef][Medline]
  13. Micheli LJ, Browne JE, Erggelet C, et al. Autologous chondrocyte implantation of the knee: multicenter experience and minimum 3-year follow-up. Clin J Sport Med 2001;11 : 223–228[CrossRef][Medline]
  14. Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 2000:212 –234
  15. Marcacci M, Berruto M, Brocchetta D, et al. Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res 2005:96 –105
  16. Minas T, Chiu R. Autologous chondrocyte implantation. Am J Knee Surg 2000; 13:41 –50[Medline]
  17. Nieminen MT, Rieppo J, Silvennoinen J, et al. Spatial assessment of articular cartilage proteoglycans with Gd-DTPA-enhanced T1 imaging. Magn Reson Med 2002;48 : 640–648[CrossRef][Medline]
  18. Williams A, Gillis A, McKenzie C, et al. Glycosaminoglycan distribution in cartilage as determined by delayed gadolinium-enhanced MRI of cartilage (dGEMRIC): potential clinical applications. AJR 2004; 182:167 –172[Abstract/Free Full Text]
  19. Williams A, Sharma L, McKenzie CA, Prasad PV, Burstein D. Delayed gadolinium-enhanced magnetic resonance imaging of cartilage in knee osteoarthritis: findings at different radiographic stages of disease and relationship to malalignment. Arthritis Rheum2005; 52:3528 –3535[CrossRef][Medline]
  20. Trattnig S, Mlynarik V, Breitenseher M, et al. MRI visualization of proteoglycan depletion in articular cartilage via intravenous administration of Gd-DTPA. Magn Reson Imaging 1999;17 : 577–583[CrossRef][Medline]
  21. Petersen EF, Fishbein KW, Laouar L, Spencer RG, Wenz JF. Ex vivo magnetic resonance microscopy of an osteochondral transfer. J Magn Reson Imaging 2003; 17:603 –608[CrossRef][Medline]
  22. Trattnig S, Marlovits S, Gebetsroither S, et al. Three-dimensional delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) for in vivo evaluation of reparative cartilage after matrix-associated autologous chondrocyte transplantation at 3.0T: preliminary results. J Magn Reson Imaging 2007; 26:974 –982[CrossRef][Medline]
  23. Roos EM, Dahlberg L. Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum 2005; 52:3507 –3514[CrossRef][Medline]
  24. Fram EK, Herfkens RJ, Johnson GA, et al. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging 1987; 5:201 –208[CrossRef][Medline]
  25. Tiderius CJ, Olsson LE, Leander P, Ekberg O, Dahlberg L. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med 2003;49 : 488–492[CrossRef][Medline]
  26. Watanabe A, Wada Y, Obata T, et al. Delayed gadolinium-enhanced MR to determine glycosaminoglycan concentration in reparative cartilage after autologous chondrocyte implantation: preliminary results. Radiology 2006;239 : 201–208[Abstract/Free Full Text]
  27. Wayne JS, Kraft KA, Shields KJ, Yin C, Owen JR, Disler DG. MR imaging of normal and matrix-depleted cartilage: correlation with biomechanical function and biochemical composition. Radiology 2003;228 : 493–499[Abstract/Free Full Text]
  28. Williams A, Mikulis B, Krishnan N, Gray M, McKenzie C, Burstein D. Suitability of T(1Gd) as the dGEMRIC index at 1.5T and 3.0T. Magn Reson Med 2007; 58:830 –834[CrossRef][Medline]
  29. Tins BJ, McCall IW, Takahashi T, et al. Autologous chondrocyte implantation in knee joint: MR imaging and histologic features at 1-year follow-up. Radiology 2005;234 : 501–508[Abstract/Free Full Text]
  30. Roberts S, McCall IW, Darby AJ, et al. Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res Ther2003; 5:R60 –R73[CrossRef][Medline]
  31. Moriya T, Wada Y, Watanabe A, et al. Evaluation of reparative cartilage after autologous chondrocyte implantation for osteochondritis dissecans: histology, biochemistry, and MR imaging. J Orthop Sci 2007; 12:265 –273[CrossRef][Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JNMHome page
L. Sarda-Mantel and D. Le Guludec
Molecular Imaging of Cartilage
J. Nucl. Med., September 1, 2009; 50(9): 1391 - 1393.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinker, K.
Right arrow Articles by Trattnig, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinker, K.
Right arrow Articles by Trattnig, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS